Total raised
—
Last: Seed 2018-02
Stage
Seed
Founded
2018
Headcount
2
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
BacoCure is developing a novel bacterial product for local therapy (intravesicular) of patients with non-muscle invasive bladder cancer. BacoCure's lead product is a novel mutated and inactivated uropathogenic bacteria that has demonstrated impressive anti-tumor effects via a novel and differentiated mechanism of action with a better safety profile compared to Bacillus Calmette-Guerin. The product is at an advanced preclinical development stage.
Funding history · 1 round · — total
2018-02
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is BacoCure's primary focus in product development?
- BacoCure is developing a novel bacterial product for local therapy (intravesicular) of patients with non-muscle invasive bladder cancer.
- What is the status of BacoCure's operations as of January 2022?
- BacoCure ceased to operate in January 2022 and is currently inactive.
- When was BacoCure founded?
- BacoCure was founded in February 2018.
- What is the current development stage of BacoCure's lead product?
- BacoCure's lead product is at an advanced preclinical development stage.
- Who were the founders of BacoCure?
- The founders of BacoCure include Ofer Mandelboim, Yutkin Vladimir, and Gili (Gilad) Bachrach.
- Which investor participated in BacoCure's Seed round in February 2018?
- Integra Holdings was an investor in BacoCure's Seed round in February 2018.
- How many employees did BacoCure have?
- BacoCure had 2 employees.
- What is the primary sector BacoCure operates in?
- BacoCure operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersPatients
Business model
B2B
Highlights
1 Patents
Tags
bacteriapharmaceuticalsnon-invasivecanceroncologypatients